JP4690049B2 - ウイルス感染に対する免疫魚 - Google Patents

ウイルス感染に対する免疫魚 Download PDF

Info

Publication number
JP4690049B2
JP4690049B2 JP2004564397A JP2004564397A JP4690049B2 JP 4690049 B2 JP4690049 B2 JP 4690049B2 JP 2004564397 A JP2004564397 A JP 2004564397A JP 2004564397 A JP2004564397 A JP 2004564397A JP 4690049 B2 JP4690049 B2 JP 4690049B2
Authority
JP
Japan
Prior art keywords
virus
fish
dna
carp
dna virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004564397A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512078A5 (https=
JP2006512078A (ja
Inventor
コトラー、モシェ
ベネット、アヤナ
ベジェラノ、イズハク
チェン、ニッシム
フトラン、マリナ
ロネン、アリエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of JP2006512078A publication Critical patent/JP2006512078A/ja
Publication of JP2006512078A5 publication Critical patent/JP2006512078A5/ja
Application granted granted Critical
Publication of JP4690049B2 publication Critical patent/JP4690049B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2004564397A 2003-01-01 2003-12-22 ウイルス感染に対する免疫魚 Expired - Fee Related JP4690049B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15377503A IL153775A0 (en) 2003-01-01 2003-01-01 Immunizing fish against viral infection
IL153775 2003-01-01
PCT/IL2003/001097 WO2004061093A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010185273A Division JP2011024584A (ja) 2003-01-01 2010-08-20 ウイルス感染に対する免疫魚

Publications (3)

Publication Number Publication Date
JP2006512078A JP2006512078A (ja) 2006-04-13
JP2006512078A5 JP2006512078A5 (https=) 2007-02-15
JP4690049B2 true JP4690049B2 (ja) 2011-06-01

Family

ID=29798413

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004564397A Expired - Fee Related JP4690049B2 (ja) 2003-01-01 2003-12-22 ウイルス感染に対する免疫魚
JP2010185273A Withdrawn JP2011024584A (ja) 2003-01-01 2010-08-20 ウイルス感染に対する免疫魚

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010185273A Withdrawn JP2011024584A (ja) 2003-01-01 2010-08-20 ウイルス感染に対する免疫魚

Country Status (12)

Country Link
US (1) US7351527B2 (https=)
EP (1) EP1578959B1 (https=)
JP (2) JP4690049B2 (https=)
CN (1) CN100535108C (https=)
AT (1) ATE507286T1 (https=)
AU (1) AU2003288510A1 (https=)
DE (1) DE60336927D1 (https=)
DK (1) DK1578959T3 (https=)
IL (2) IL153775A0 (https=)
PL (1) PL209978B1 (https=)
RU (1) RU2369635C2 (https=)
WO (1) WO2004061093A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109114B2 (ja) * 2006-02-24 2012-12-26 国立大学法人三重大学 魚類抗体産生の新規検出法
WO2007119279A1 (ja) * 2006-04-13 2007-10-25 National University Corporation Tokyo University Of Marine Science And Technology コイヘルペスウイルス（ｋｈｖ）病用ｄｎａワクチン
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
BRPI0816134A2 (pt) * 2007-08-28 2015-07-28 Université de Liège Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença.
EP2031065A1 (en) * 2007-08-28 2009-03-04 Université de Liège A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5462518B2 (ja) * 2009-04-09 2014-04-02 公益財団法人ヒューマンサイエンス振興財団 抗体精製方法
EP2487241A1 (en) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi agents and compositions useful as carp therapeutics
EP2797627B1 (en) * 2011-12-30 2020-10-07 Gesval s.a. A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
CA2905257C (en) * 2013-03-15 2022-03-15 Atlantium Technologies Ltd. System and method for inactivation of infectious pancreatic necrosis virus (ipnv) using optimized ultraviolet (uv) light
JP6406703B2 (ja) * 2013-05-15 2018-10-17 国立研究開発法人水産研究・教育機構 コイ科ヘルペスウイルス−２（Ｃｙｐｒｉｎｉｄｈｅｒｐｅｓｖｉｒｕｓ−２：ＣｙＨＶ−２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ−２ウイルス製造方法
CN103430936A (zh) * 2013-09-06 2013-12-11 中国水产科学研究院黑龙江水产研究所 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104774802B (zh) * 2015-04-27 2017-12-08 上海海洋大学 银鲫鱼背鳍细胞系
RU2640346C1 (ru) * 2016-08-11 2017-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) Способ антиоксидантной защиты мальков карпа
EP3897703A2 (en) 2018-12-21 2021-10-27 Intervet International B.V. Serum free intracellular pathogen vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
AU2003288510A8 (en) 2004-07-29
EP1578959A1 (en) 2005-09-28
AU2003288510A1 (en) 2004-07-29
DE60336927D1 (https=) 2011-06-09
ATE507286T1 (de) 2011-05-15
DK1578959T3 (da) 2011-08-15
JP2011024584A (ja) 2011-02-10
RU2369635C2 (ru) 2009-10-10
IL153775A0 (en) 2003-07-31
WO2004061093A1 (en) 2004-07-22
US20060013828A1 (en) 2006-01-19
JP2006512078A (ja) 2006-04-13
EP1578959B1 (en) 2011-04-27
CN1742083A (zh) 2006-03-01
IL169412A (en) 2011-04-28
PL376441A1 (en) 2005-12-27
US7351527B2 (en) 2008-04-01
PL209978B1 (pl) 2011-11-30
CN100535108C (zh) 2009-09-02
RU2005120158A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
JP2011024584A (ja) ウイルス感染に対する免疫魚
TWI442935B (zh) 豬第二型環狀病毒（Ｐｏｒｃｉｎｅ Ｃｉｒｃｏｖｉｒｕｓ Ｔｙｐｅ ２）、含彼之免疫組合物、檢測套組及其應用
Singh et al. Buffalopox: an emerging and re-emerging zoonosis
KR101243871B1 (ko) 개 파보바이러스의 유전자 변이체를 포함하는 백신
US8178110B2 (en) Reovirus compositions and methods of use
TWI799365B (zh) 用於先天性痙攣症之瘟疫病毒疫苗
Borie et al. Microbiological hazards related to xenotransplantation of porcine organs into man
Bhuyan et al. The construction of recombinant Lactobacillus casei expressing BVDV E2 protein and its immune response in mice
TW201731526A (zh) 混成核心之貓科動物疫苗
CN118480515B (zh) 一种猪繁殖与呼吸综合征病毒nadc30病毒株及其应用
Garland et al. Attempts to infect pigs with coxsackie virus type B5
KR100977306B1 (ko) 닭 전염성 ｆ낭병 바이러스의 유전자 재조합 ｖｐ２단백질및 이를 포함하는 닭 전염성 ｆ낭병 진단시약
KR20230084078A (ko) 제3 유전자형 e형 간염 바이러스 캡시드 단백질의 면역원성 단편 또는 이의 바이러스-유사 입자를 포함하는 e 형 간염의 예방 또는 치료용 백신 조성물
Abd El-Ghany Forms of avian reovirus in poultry production: An overview
CN118931848B (zh) 一种猪圆环病毒3型病毒株及其应用
CN110923248B (zh) 猪繁殖与呼吸综合征病毒、疫苗及其制备方法和用途
KR100391265B1 (ko) 흑염소 로타 바이러스 순화주, 이의 제조 방법 및 용도
Masiuk et al. MICROBIOCENOSIS OF THE INTESTINES OF PIGLETS IN THE CLINICAL COURSE OF PIG EPIDEMIC DIARRHEA
Korsman Characterization and sequence variation of the virulence-associated proteins of different tissue culture isolates of African Horsesickness Virus serotype 4
Srivastava et al. NEPHROTIC SYNDROME IN A SIAMESE CAT
Hayford Characterization and Genotyping of Rotaviruses from Communities in Akuse District and Its Environs.
Müller Virus-Host Adatation and Co-Evolution of Myxoma Virus (Mv) and Rabbit Haemorrhagic Disease Virus (Rhdv) in Their Natural Host, the Wild Rabbit (Oryctolagus Cuniculus)
Ilouze et al. Characterization of a Novel Virus Causing
Prince The cotton rat as a model of Respiratory Syncytial Virus pathogenesis, prophylaxis and therapy
Abbassi et al. The following abstracts are from the oral and poster sessions presented at the Poultry Medicine Section of the 1999 AVMA Annual Convention in New Orleans, La, July 10-July 14, 1999. Abstracts for the Poultry Medicine Section

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090721

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091016

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091023

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091124

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091221

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100820

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100924

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110118

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110217

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140225

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees